New insights into the molecular and epigenetic effects of antitumor Pt(IV)-valproic acid conjugates in human ovarian cancer cells.

Abstract

Substitutionally inert Pt(IV) prodrugs, combining bioactive axial ligands with Pt(IV) derivatives of antitumor Pt(II) compounds, represent a new generation of anticancer drugs. The rationale behind these prodrugs is to release, by reductive elimination inside the cancer cell, an active Pt(II) drug which binds nuclear DNA as well as bioactive ligands that may potentiate toxic effects of the Pt(II) drugs by an independent pathway. Platinum prodrugs, such as Pt(IV) derivatives of cisplatin containing axial valproic acid (VPA) ligands, destroy cancer cells with greater efficacy than conventional cisplatin. These axial ligands were chosen because VPA inhibits histone deacetylase (HDAC) activity, thereby decondensing chromatin and subsequently increasing the accessibility of DNA within chromatin to DNA-binding agents. We examined the mechanism of cytotoxic activity of Pt(IV) derivatives of cisplatin with VPA axial ligands. Particular attention was paid to the role of the VPA ligand in these Pt(IV) prodrugs in the mechanism underlying their toxic effects in human ovarian tumor cells. We demonstrate that (i) treatment of the cells with these prodrugs resulted in enhanced histone H3 acetylation and decondensation of heterochromatin markedly more effectively than free VPA; (ii) of the total Pt inside the cells, a considerably higher fraction of Pt from the Pt(IV)-VPA conjugates is bound to DNA than from the conjugates with biologically inactive ligands. The results indicate that the enhanced cytotoxicity of the Pt(IV)-VPA conjugates is a consequence of several processes involving enhanced cellular accumulation, downregulation of HDACs and yet other biochemical processes (not involving HDACs) which may potentiate antitumor effects.

• Authors: Vojtech Novohradsky, Lenka Zerzankova, Jana Stepankova, Oldrich Vrana, Raji Raveendran, Dan Gibson, Jana Kasparkova, Viktor Brabec
• Journal: Biochemical pharmacology (Biochem Pharmacol) Vol. 95 Issue 3 Pg. 133-44 (Jun 01 2015) ISSN: 1873-2968 [Electronic] England
• PMID: 25888926 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2015 Elsevier Inc. All rights reserved.

Chemical References

• Histones
• Organoplatinum Compounds
• Valproic Acid
• Histone Deacetylases
• Glutathione

Topics

• Acetylation
• Cell Line, Tumor
• Epigenesis, Genetic
• Female
• Glutathione (metabolism)
• Histone Deacetylases (metabolism)
• Histones (metabolism)
• Humans
• Magnetic Resonance Spectroscopy
• Organoplatinum Compounds (chemistry, metabolism)
• Ovarian Neoplasms (genetics, metabolism, pathology)
• Valproic Acid (chemistry, metabolism)